Hormonal
Low-carbohydrate diets reduce insulin resistance primarily through weight loss and ketosis, though evidence is mixed and long-term safety is debated.
If you try a low-carb diet, expect weight loss to be the main driver of improved insulin sensitivity. Ensure you are getting enough fiber and nutrients, as strict low-carb diets can lack certain vitamins and minerals. Monitor your progress, but don't assume low-carb is inherently superior to other balanced diets if weight loss is similar.
Düşük karbonhidratlı diyetlerin metabolizmada yol açtığı önemli değişikliklerinden biri ketoz durumudur... Azalan glikoz alımı insülin düzeylerinin dolayısıyla insülin direncinin iyileştirilmesine katkıda bulunabilmektedir... Güncel çalışmalarda, bu tür diyetlerin açlık glukoz ve insülin ve trigliserit düzeylerinde düşüş, hızlı vücut ağırlığı kaybı ve kan basıncının regülasyonunu sağlayabileceği düşünülmektedir.
Why this rating
The paper cites multiple studies with conflicting results and notes that more research is needed.
Source
İnsülin Direncinin Beslenme Tedavisinde Güncel Diyet Modelleri
Meryem Köpürlü et al. · İstanbul Sabahattin Zaim Üniversitesi Fen Bilimleri Enstitüsü Dergisi · 2024
DOI 10.47769/izufbed.1319354
More from this paper
- Low-glycemic index diets improve insulin sensitivity and glycemic control, primarily through weight loss and reduced postprandial glucose spikes.Good
- High-fiber diets improve insulin sensitivity and glycemic control, primarily through weight loss and reduced postprandial glucose spikes.Good
- DASH and Mediterranean diets improve insulin sensitivity and glycemic control, primarily through weight loss and improved diet quality.Good
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →